These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34756636)

  • 1. Corrigendum to "Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study" [International Journal of Antimicrobial Agents, Volume 54, Issue 5 (2019) 572-578].
    Echeverria-Esnal D; Sorli L; Prim N; Conde-Estévez D; Mateu-De Antonio J; Martin-Ontiyuelo C; Horcajada JP; Grau S
    Int J Antimicrob Agents; 2021 Dec; 58(6):106455. PubMed ID: 34756636
    [No Abstract]   [Full Text] [Related]  

  • 2. Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study.
    Echeverria-Esnal D; Sorli L; Prim N; Conde-Estévez D; Mateu-De Antonio J; Martin-Ontiyuelo C; Horcajada JP; Grau S
    Int J Antimicrob Agents; 2019 Nov; 54(5):572-578. PubMed ID: 31476435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First outbreak of colonization by linezolid- and glycopeptide-resistant Enterococcus faecium harbouring the cfr gene in a UK nephrology unit.
    Inkster T; Coia J; Meunier D; Doumith M; Martin K; Pike R; Imrie L; Kane H; Hay M; Wiuff C; Wilson J; Deighan C; Hopkins KL; Woodford N; Hill R
    J Hosp Infect; 2017 Dec; 97(4):397-402. PubMed ID: 28698020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin versus Glycopeptides for the Treatment of
    Echeverría-Esnal D; Sorli L; Prim N; Martin-Ontiyuelo C; Horcajada JP; Grau S
    Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34198646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid treatment of glycopeptide-resistant Enterococcus faecium in very low birth weight premature neonates.
    Hoehn R; Groll AH; Schaefer V; Bauer K; Schloesser RL
    Int J Antimicrob Agents; 2006 Mar; 27(3):256-8. PubMed ID: 16480855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.
    Marcadé G; Micol JB; Jacquier H; Raskine L; Donay JL; Nicolas-Viaud S; Rouveau M; Ribaud P; Dombret H; Leclercq R; Cambau E
    J Antimicrob Chemother; 2014 Feb; 69(2):500-5. PubMed ID: 24092659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia in cancer patients.
    Conde-Estévez D; Grau S; Albanell J; Terradas R; Salvadó M; Knobel H
    Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):103-8. PubMed ID: 20711795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates.
    Raponi G; Ghezzi MC; Gherardi G; Lorino G; Dicuonzo G
    J Med Microbiol; 2010 Jun; 59(Pt 6):672-678. PubMed ID: 20185550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin.
    Bager F; Aarestrup FM; Madsen M; Wegener HC
    Microb Drug Resist; 1999; 5(1):53-6. PubMed ID: 10332722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).
    Ballow CH; Biedenbach DJ; Rossi F; Jones RN;
    Braz J Infect Dis; 2002 Jun; 6(3):100-9. PubMed ID: 12144745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.
    Klare I; Konstabel C; Mueller-Bertling S; Werner G; Strommenger B; Kettlitz C; Borgmann S; Schulte B; Jonas D; Serr A; Fahr AM; Eigner U; Witte W
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):815-25. PubMed ID: 16374593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci.
    Abele-Horn M; Hommers L; Trabold R; Frosch M
    J Clin Microbiol; 2006 Jan; 44(1):71-6. PubMed ID: 16390951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of ampicillin and glycopeptide resistant Enterococcus faecium VanA bacteraemia in Greece.
    Kouppari G; Papadaki H; Arida C; Sakellariou J; Legakis NJ; Papaparaskevas J
    Int J Antimicrob Agents; 2000 Nov; 16(3):254-6. PubMed ID: 11185546
    [No Abstract]   [Full Text] [Related]  

  • 15. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
    Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
    Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
    J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.
    Foo H; Chater M; Maley M; van Hal SJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2252-7. PubMed ID: 24744303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
    McBride SJ; Upton A; Roberts SA
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):107-14. PubMed ID: 19916034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activity of linezolid against staphylococci and enterococci isolated in Italy.
    Stefani S; Mezzatesta ML; Tempera G; Debbra E; Schito AM; Nicoletti G; Marchére A
    Clin Microbiol Infect; 2002 Jun; 8(6):368-72. PubMed ID: 12084106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia.
    Suppola JP; Kuikka A; Vaara M; Valtonen VV
    Scand J Infect Dis; 1998; 30(2):153-7. PubMed ID: 9730302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.